New York, NY -- (SBWire) -- 03/21/2018 --Description:

The analysts forecast the global critical care therapeutics market to grow at a CAGR of 3.62% during the period 2017-2021.

Critical care or intensive care is the close monitoring and treatment given to individuals with acute, life-threatening illness or injuries such as shock, burns, accidents, complicated surgeries, sepsis, and severe breathing problems. It usually takes place in an ICU or trauma center. Plasma is the fluid portion of the blood, in which all the blood cells are suspended. It makes up about 55% of the total volume of the blood. The other components such as red blood cell (RBC), white blood cell (WBC), and platelets together comprise the remaining 45% of the blood. Plasma is mainly made up of water, which accounts for about 91% of the total volume.

Get a Sample Report @ https://www.wiseguyreports.com/sample-request/1237686-global-critical-care-therapeutics-market-2017-2021

For more information or any query mail at sales@wiseguyreports.com

Covered in this report
The report covers the present scenario and the growth prospects of the global critical care therapeutics market for 2017-2021. To calculate the market size, the report considers the revenue generated from sales of critical care therapeutics was considered.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

The report, Global Critical Care Therapeutics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- CSL Behring
- Grifols
- Kedrion Biopharma
- Octapharma
- Shire

Other prominent vendors
- Abeona Therapeutics
- ADMA Biologics
- Albumedix
- Armetheon
- Asklepios BioPharmaceutical
- Aspen Pharma
- Baxter
- Bayer HealthCare
- Bio Products Laboratory
- BioDelivery Sciences
- Biogen Idec
- BioMarin
- Biotest Pharmaceuticals
- Bristol-Myers Squibb
- Catalyst Biosciences
- China Biologic Products
- Cosmo Pharmaceuticals
- Kamada
- King Pharmaceuticals
- Medxbio
- Merck
- Mitsubishi Tanabe Pharma
- Novo Nordisk
- Novozymes
- Portola Pharmaceuticals
- ProMetic Life Sciences
- rEVO Biologics
- Rockwell Medical
- Sanquin
- Shanghai RAAS
- Teva Pharmaceutical
- The Medicines Company
- Thermo Fisher Scientific
- Tianjin SinoBiotech & Beijing Bio-Fortune
- Ventria Bioscience

Market driver
- Growing preference for marketed products over alternative treatment options.
- For a full, detailed list, view our report

Market challenge
- Existence of plasma fractionation supply and demand gap.
- For a full, detailed list, view our report

Market trend
- Increased development of recombinant products for critical care use.
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2021 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Complete Report Details @ https://www.wiseguyreports.com/reports/1237686-global-critical-care-therapeutics-market-2017-2021

Table Of Contents – Major Key Points

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

- Key market highlights
- The role of plasma therapeutics in critical care industry
- Introduction to plasma therapeutics
- Introduction to anticoagulants

PART 05: Global critical care therapeutics: Market landscape
- Market overview
- Five forces analysis

PART 06: Market segmentation by drug class
- Global albumin market
- Global prothrombin complex concentrates market
- Global antithrombin concentrates market
- Global factor XIII concentrates market
- Global fibrinogen concentrates market

PART 07: Market segmentation by application
- DVT
- Pulmonary embolism (PE)
- Acute coronary syndrome
- Atrial fibrillation
- Hemodialysis
- Coronary angioplasty
- Surgeries

PART 08: Geographical segmentation
- Critical care therapeutics market in Americas
- Critical care therapeutics market in EMEA
- Critical care therapeutics market in APAC

PART 09: Market drivers
- High demand for albumin in China
- Increasing surgical procedures
- Growing preference for marketed products over alternative treatment options
- Impact of drivers

PART 10: Market challenges
- Existence of plasma fractionation supply and demand gap
- Spread of pathogenic contaminants
- High regulations of plasma products

PART 11: Impact of drivers and challenges

PART 12: Market trends
- Increased development of recombinant products for critical care use
- Establishment of plasma fractionation facilities in emerging economies by global players
- Strategic initiatives of vendors fueling the market growth

PART 13: Vendor landscape
- Competitive scenario
- Other prominent vendors

PART 14: Key vendor analysis
- CSL Behring
- Grifols
- Kedrion Biopharma
- Octapharma
- Shire

Continue……

For more information or any query mail at sales@wiseguyreports.com

About Wise Guy Reports
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.